ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

RUCONEST
Hereditary angioedema
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

RUCONEST Rx

Generic Name and Formulations:
C1 esterase inhibitor (recombinant) 2100 IU; per vial; lyophilized pwd for IV inj after reconstitution; preservative-free.

Company:
Valeant Pharmaceuticals, Inc

Therapeutic Use:

Indications for RUCONEST:

Treatment of acute attacks in adult and adolescent patients with hereditary angioedema (HAE).

Limitations Of use:

Efficacy not established in hereditary angioedema (HAE) patients with laryngeal attacks.

Adult:

Give by slow IV inj over 5 mins. <84kg: 50 IU/kg. ≥84kg: 4200 IU. Max 4200 IU/dose. May give second dose if attack symptoms persist; max 2 doses/24hrs.

Children:

Not established.

Contraindications:

Allergy to rabbits or rabbit-derived products.

Warnings/Precautions:

Discontinue if hypersensitivity reactions occur. Monitor patients with known risk factors for thrombotic events (eg, indwelling venous catheter, history of thrombosis, atherosclerosis, morbid obesity, immobility). Labor & delivery. Pregnancy (Cat.B). Nursing mothers.

Interactions:

Risk of thrombotic events with concomitant oral contraceptives or certain androgens.

Pharmacological Class:

C1 inhibitor.

Adverse Reactions:

Headache, nausea, diarrhea; thrombotic events, hypersensitivity reactions (may be severe).

How Supplied:

Single-use vial—1

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs